IP Library Granted Patent US 8,263,137
Granted Patent B2
US 8,263,137 · App. 12/053,073 · Granted Sep 11, 2012

Nutritional supplement for women

Assignee: Vertical Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,263,137
App. No.
12/053,073
Granted
Sep 11, 2012
Kind
B2
Abstract

A nutritional supplement comprising a variety of vitamins and minerals is described. A nutritional supplement comprising between about 1 mg and about 5 mg of vitamin B 1 , between about 2 mg and about 8 mg of vitamin B 2 , between about 7 mg and about 30 mg of vitamin B 6 , between about 10 mcg and about 40 mcg of vitamin B 12 , between about 1 mg and about 4 mg of folic acid, between about 250 IU and about 900 IU of vitamin D 3 , between about 100 mg and about 400 mg of vitamin C, between about 20 IU and about 90 IUs of vitamin E, between about 0.5 mg and about 4 mg of copper, between about 20 mg and about 80 mg of zinc, between about 10 mg and about 70 mg of iron, and between about 100 mg and about 800 mg of omega-3 fatty acids is disclosed.

Claims (68)

1. A nutritional supplement composition consisting of:

between about 1 mg and about 5 mg of vitamin B 1 ;

between about 2 mg and about 8 mg of vitamin B 2 ;

between about 7 mg and about 30 mg of vitamin B 6 ;

between about 10 mcg and about 40 mcg of vitamin B 12 ;

between about 1 mg and about 4 mg of folic acid;

between about 250 IU and about 900 IU of vitamin D 3 ;

between about 100 mg and about 400 mg of vitamin C;

between about 20 IU and about 90 IUs of vitamin E;

between about 0.5 mg and about 4 mg of copper;

between about 20 mg and about 80 mg of zinc;

between about 10 mg and about 70 mg of iron; and

between about 100 mg and about 800 mg of omega-3 fatty acids.

2. The composition of claim 1 , wherein the nutritional supplement is administered in a form selected from the group consisting of a pill, a tablet, a caplet, a capsule, a chewable tablet, a quick dissolve tablet, a powder, an effervescent tablet, a hard gelatin capsule, and a soft gelatin capsule.

3. The composition of claim 2 , wherein the nutritional supplement is administered in a form with an enteric coating.

4. The composition of claim 1 , wherein vitamin B 12 is in the form of cyanocobalamin.

5. The composition of claim 1 , wherein vitamin E is in the form of a tocopherol.

6. The composition of claim 1 , wherein the nutritional supplement is administered in the form of a liquid suspension.

7. The composition of claim 1 , wherein the nutritional supplement is administered in the form of a food product.

8. The composition of claim 1 , wherein the omega-3 fatty acids comprise docosahexaenoic acid and eicosapentaenoic acid.

9. A nutritional supplement composition consisting of:

about 2 mg of vitamin B 1 ;

about 3.4 mg of vitamin B 2 ;

about 10 mg of vitamin B 6 ;

about 15 mcg of vitamin B 12 ;

about 1.25 mg of folic acid;

about 400 IU of vitamin D 3 ;

about 120 mg of vitamin C;

about 30 IU of vitamin E;

about 1 mg of copper;

about 25 mg of zinc;

about 28 mg of iron; and

about 200 mg of omega-3 fatty acids.

10. The composition of claim 9 , wherein the nutritional supplement is administered in a form selected from the group consisting of a pill, a tablet, a caplet, a capsule, a chewable tablet, a quick dissolve tablet, a powder, an effervescent tablet, a hard gelatin capsule, and a soft gelatin capsule.

11. The composition of claim 10 , wherein the nutritional supplement is administered in a form with an enteric coating.

12. The composition of claim 9 , wherein the nutritional supplement is administered in the form of a liquid suspension.

13. The composition of claim 9 , wherein the nutritional supplement is administered in the form of a food product.

14. The composition of claim 9 , wherein vitamin B 12 is in the form of cyanocobalamin.

15. The composition of claim 9 , wherein vitamin E is in the form of a tocopherol.

16. The composition of claim 9 , wherein the omega-3 fatty acids comprise docosahexaenoic acid and eicosapentaenoic acid.

17. A method comprising the step of:

administering to an individual a composition consisting of:

between about 2 mg and about 4 mg of vitamin B 1 ;

between about 3.4 mg and about 6.8 mg of vitamin B 2 ;

between about 10 mg and about 20 mg of vitamin B 6 ;

between about 15 mcg and about 30 mcg of vitamin B 12 ;

between about 1.25 mg and about 2.50 mg of folic acid;

between about 400 IU and about 800 IU of vitamin D 3 ;

between about 120 mg and about 240 mg of vitamin C;

between about 30 IU and about 60 IUs of vitamin E;

between about 1 mg and about 2 mg of copper;

between about 25 mg and about 50 mg of zinc;

between about 28 mg and about 56 mg of iron; and

between about 200 mg and about 400 mg of omega-3 fatty acids.

18. The method of claim 17 , wherein the omega-3 fatty acids of the composition comprise docosahexaenoic acid and eicosapentaenoic acid.

19. A nutritional supplement composition consisting of:

between about 1 mg and about 5 mg of vitamin B 1 ;

between about 2 mg and about 8 mg of vitamin B 2 ;

between about 7 mg and about 40 mg of vitamin B 6 ;

between about 5 mcg and about 50 mcg of vitamin B 12 ;

between about 1 mg and about 4 mg of folic acid;

between about 250 IU and about 1000 IU of vitamin D 3 ;

between about 75 mg and about 400 mg of vitamin C;

between about 20 IU and about 90 IUs of vitamin E;

between about 0.5 mg and about 4 mg of copper;

between about 15 mg and about 80 mg of zinc;

between about 10 mg and about 70 mg of iron; and

between about 100 mg and about 800 mg of omega-3 fatty acids.

Assignments (7)
SECURITY INTEREST Recorded Jun 30, 2023
From: VERTICAL PHARMACEUTICALS, LLC
To: CIBC BANK USA
Reel/Frame 064133/0094 →
RELEASE OF SECURITY INTEREST Recorded Aug 28, 2021
From: CIT BANK, N.A., AS COLLATERAL AGENT
To: VERTICAL PHARMACEUTICALS, LLC
Reel/Frame 057319/0886 →
SECURITY INTEREST Recorded Aug 27, 2021
From: VERTICAL PHARMACEUTICALS, LLC
To: CIBC BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 057309/0950 →
SECURITY INTEREST Recorded Feb 3, 2016
From: VERTICAL PHARMACEUTICALS, LLC
To: CIT BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 037656/0879 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2013
From: SDK VC PHARMA HOLDING CORP.
To: VERTICAL PHARMACEUTICALS, LLC
Reel/Frame 031767/0691 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2013
From: VERTICAL PHARMACEUTICALS, INC.
To: SDK VC PHARMA HOLDING CORP.
Reel/Frame 031767/0553 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2008
From: SQUASHIC, STEVEN A; HUDY, KEVIN M.; PURDY, DAVID C.
To: VERTICAL PHARMACEUTICALS, INC.
Reel/Frame 021020/0263 →
Continuity (2)
Continuation In Part 11197760 · Aug 4, 2005
Related Publication 20080226746A1 · Sep 18, 2008